GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PsyBio Therapeutics Corp (OTCPK:PSYBF) » Definitions » Ending Cash Position

PsyBio Therapeutics (PsyBio Therapeutics) Ending Cash Position : $0.04 Mil (As of Jun. 2023)


View and export this data going back to 2021. Start your Free Trial

What is PsyBio Therapeutics Ending Cash Position?

PsyBio Therapeutics's Ending Cash Position for the quarter that ended in Jun. 2023 was $0.04 Mil.

PsyBio Therapeutics's quarterly Ending Cash Position declined from Dec. 2022 ($0.16 Mil) to Mar. 2023 ($0.09 Mil) and declined from Mar. 2023 ($0.09 Mil) to Jun. 2023 ($0.04 Mil).

PsyBio Therapeutics's annual Ending Cash Position increased from . 20 ($0.00 Mil) to Dec. 2021 ($0.12 Mil) and increased from Dec. 2021 ($0.12 Mil) to Dec. 2022 ($0.16 Mil).

PsyBio Therapeutics Ending Cash Position Historical Data

The historical data trend for PsyBio Therapeutics's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PsyBio Therapeutics Ending Cash Position Chart

PsyBio Therapeutics Annual Data
Trend Dec21 Dec22
Ending Cash Position
0.12 0.16

PsyBio Therapeutics Quarterly Data
Dec19 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.06 0.18 0.16 0.09 0.04

PsyBio Therapeutics Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

PsyBio Therapeutics's Ending Cash Position for the fiscal year that ended in Dec. 2022 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=0.125+0.032
=0.16

PsyBio Therapeutics's Ending Cash Position for the quarter that ended in Jun. 2023 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=-0.858+0.901
=0.04

PsyBio Therapeutics Ending Cash Position Related Terms

Thank you for viewing the detailed overview of PsyBio Therapeutics's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

PsyBio Therapeutics (PsyBio Therapeutics) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PsyBio Therapeutics Corp (OTCPK:PSYBF) » Definitions » Ending Cash Position
Comparable Companies
XCNQ:CURE XCNQ:AGN TSXV:VXL TSXV:SVS XCNQ:MOOD XCNQ:GTTX TSXV:IBO XCNQ:ENBI XCNQ:ABRT XCNQ:MYND OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
PSYB:Canada
Address
4400 Sample Road, Suite 138, Coconut Creek, FL, USA, 33073
Website
https://www.psybiolife.com
PsyBio Therapeutics Corp is a biotechnology company. The company is engaged in the development of drugs intended for the treatment of mental illness and neurological disorders.

PsyBio Therapeutics (PsyBio Therapeutics) Headlines

From GuruFocus

PsyBio Announces Second Quarter Financial Results of Leo Acquisition Corp.

By GlobeNewswire GlobeNewswire • 03-02-2021

PsyBio Therapeutics to Present at the KCSA Psychedelics Virtual Investor Conference on October 14th

By PRNewswire PRNewswire • 10-11-2021

PsyBio Therapeutics Announces Uplisting to OTCQB Venture Market

By PRNewswire PRNewswire • 07-14-2021